Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation.
First Department of Internal Medicine (Hematology/Oncology), Tokyo Medical University, Tokyo, 160-0023, Japan.
Daigo
D
Akahane
First Department of Internal Medicine (Hematology/Oncology), Tokyo Medical University, Tokyo, 160-0023, Japan.
Yoshikazu
Y
Ito
First Department of Internal Medicine (Hematology/Oncology), Tokyo Medical University, Tokyo, 160-0023, Japan.
Masahiko
M
Sumi
First Department of Internal Medicine (Hematology/Oncology), Tokyo Medical University, Tokyo, 160-0023, Japan.
Tetsuzo
T
Tauchi
First Department of Internal Medicine (Hematology/Oncology), Tokyo Medical University, Tokyo, 160-0023, Japan.
Yukihiko
Y
Kimura
First Department of Internal Medicine (Hematology/Oncology), Tokyo Medical University, Tokyo, 160-0023, Japan. ohyashik@rr.iij4u.or.jp.
Kazuma
K
Ohyashiki
D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D008875:Middle Aged; D012008:Recurrence; D013997:Time Factors; D014184:Transplantation, Homologous